K-RAS and EGFR in Lung Cancer

计划入组 424 人 · 首次发布于 2019 年 5 月 15 日

Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)

计划入组 52 人 · 首次发布于 2011 年 1 月 24 日

Lymph Node Ratio and Kras Mutation in R Colon Cancer

计划入组 433 人 · 首次发布于 2020 年 4 月 13 日

prenylated K-Ras G12V inhibitors (cancer)

pbi-shRN K-ras LP

K-RAS (Sibylla)

KIM IVANA K

United States

Dr. Tapas K. Das Gupta

K-Group Beta, Inc.

United States

Akari Therapeutics Reports Promising Preclinical Data for AKTX-101 in K-Ras Mutant Pancreatic Cancer

Quanta Therapeutics' QTX3034 Receives FDA IND Clearance for KRASG12D-Mutated Solid Tumors

Revolution Medicines Advances First-in-Class KRAS(G12D) Molecular Glue Inhibitor RMC-9805 with Novel Cyclophilin A Mechanism